Algo version: 0.98b
Global Cord Blood is listed at the NYSE Exchange
Global Cord Blood [CO]
NYSE Sector: Healthcare Industry:Medical - Diagnostics & Research

Is Global Cord Blood stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Global Cord Blood pays dividends. Last time was Monday 20th of August 2018 where the investors holding the stock on Tuesday 31st of July 2018 were paid $0.08 per share. Over the last 2 times between 2018 and 2018, Global Cord Blood has paid $0.16 with an average of $0.08 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Global Cord Blood 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was $5.67, you would have made a loss of $-2.68 per share or -47.31%

No, the average daily trading liquidity for Global Cord Blood is $177 415 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Global Cord Blood has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 4 174.20, the company's ability to pay off the debt is good. Global Cord Blood has a very good net profit margin of 40.30% and should have very high tolerances against inflation.

We have calculated the inflation risk for Global Cord Blood to be low [0 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.